Glipizide Api

Product Description

Glipizide is an ATP dependent K+ channels blocker in pancreatic B cells and brain GABA containing neurons resulting in insulin release.

Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.

Premium Quality Medicine Grade

Our Glipizide API is offered in medicine grade, ensuring suitability for pharmaceutical applications. The white crystalline powder is processed to a high degree of purity (99%), making it ideal for the production of reliable and effective anti-diabetic formulations. This API complies with international standards required for medicinal intermediates.


Reliable Shelf Life and Stability

Glipizide API features an extended shelf life of 5 years, ensuring long-term usability and stability in your formulations. With proper storage conditions, the quality and efficacy of the powder remain intact, giving manufacturers greater flexibility in inventory planning and pharmaceutical development.


Trusted Exporter from India

As an established supplier, exporter, and trader based in India, we are dedicated to meeting global industry demands for Glipizide API. Our streamlined processes ensure timely supply and adherence to export regulations, making us a reliable choice for pharmaceutical companies worldwide.